微细胞外囊泡诱导与阿尔茨海默病相关的皮质-海马体网络功能障碍
Chiara Falcicchia1, Francesca Tozzi1,2, Martina Gabrielli3
1National Research Council (CNR) Institute of Neuroscience, Pisa 56124, Italy.
Brain communications
|June 8, 2023
概括
携带β-粉样蛋白 (Aβ) 的细胞外囊泡传播阿尔茨海默病的病理,导致网络功能障碍和记忆丧失. 抑制囊泡运动显著减少了这些影响,提供了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- β-粉样蛋白 (Aβ) 是阿尔茨海默病 (AD) 的一个关键标志,导致突触功能障碍和行为异常.
- 通过Aβ在神经回路中传播的确切机制尚不清楚.
- 携带Aβ的微质衍生的细胞外囊泡 (EVs) 已涉及到启动和传播内-海马回路中的突触功能障碍.
研究的目的:
- 调查细胞外囊泡 (EV) 介导的Aβ传播在阿尔茨海默氏病 (AD) 发病过程中的作用.
- 为了确定是否注入Aβ携带的EVs进入内皮质可以诱导AD类似的网络和记忆改变.
- 在AD模型中评估抑制EV运动的治疗潜力.
主要方法:
- 慢性脑电图 (EEG) 记录在小鼠身上.
- 将携带Aβ的EV注入老鼠内腔皮层的立体注射.
- 使用对象识别和对象位置上下文识别任务评估记忆功能.
- 药理上抑制了EV运动.
主要成果:
- 单次注射Aβ载体EV诱导皮质和海马网络的EEG异常,模仿AD.
- 脑电图变化与协会和非协会任务中的渐进性记忆障碍相关.
- 抑制EV运动性显著减轻了网络不稳定性和内存缺陷.
- EV运动性对于Aβ病理的进展和相关的认知衰退至关重要.
结论:
- 细胞外囊泡 (EVs) 中介于β-粉样蛋白 (Aβ) 病理的传播,在小鼠模型中驱动网络功能障碍和记忆障碍.
- 这项研究阐明了通过EV运动性进行Aβ进展的新机制.
- 针对EV介导的Aβ传播,为早期阿尔茨海默病提供了一个有前途的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


